# A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

> **NCT03582137** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 74 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Cannabidiol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03582137
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-05
- **Primary completion:** 2022-01-04
- **Final completion:** 2022-01-04
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2024-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03582137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03582137, "A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03582137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*